Cogent Biosciences

Filed a patent for "compounds for fgfrs inhibitors" on Mon, August 7, 2023

Filed a patent for "compounds for fgfr inhibition" on Fri, October 13, 2023

Filed a patent for "compounds for fgfr inhibition" on Fri, December 22, 2023

Filed a patent for "pik3 inhibitors" on Fri, July 28, 2023

Filed a patent for "erbb2 inhibitors" on Tue, April 11, 2023

Filed a patent for "compounds for fgfrs inhibitors" on Tue, January 10, 2023

Filed a patent for "compounds for fgfrs inhibitors" on Thu, August 15, 2024

Filed a patent for "chimeric receptor polypeptides in combination with trans metabolism molecules that re-direct glucose metabolites out of the glycolysis pathway and therapeutic uses thereof" on Tue, March 26, 2024

Filed a patent for "bezuclastinib formulations" on Thu, December 22, 2022